Controlled delivery of intermittent stress augmentation pacing for cardioprotective effect

• US 7,366,568 B2
• Filed: 06/13/2005
• Issued: 04/29/2008
• Est. Priority Date: 05/06/2005
• Status: Expired due to Fees

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Spinelli, Julio C., Pastore, Joseph M.
• Primary Examiner(s): Layno; Carl
• Assistant Examiner(s): Gedeon; Brian T.
• Application Number:
  US11/151,015
• Publication Number:
  US 20060253156A1
• Time in Patent Office: 1,051 Days
• Field of Search: 607/9, 607/17, 607/27
• US Class Current: 607/9
• CPC Class Codes: A61N 1/365 controlled by a physiological parameter, e.g. heart potential evoked response A61N1/371
• CPC Class Codes: A61N 1/36557 controlled by chemical substances in blood
• CPC Class Codes: A61N 1/3684 for stimulating the heart at multiple sites of the ventricle or the atrium
• CPC Class Codes: A61N 1/36842 Multi-site stimulation in the same chamber
• CPC Class Codes: A61N 1/36843 Bi-ventricular stimulation
• CPC Class Codes: A61N 1/3688 configured for switching the pacing mode, e.g. from AAI to DDD
• CPC Class Codes: A61N 1/3702 Physiological parameters A61N1/365 takes precedence; evoked response A61N1/371

Abstract

A device and method for delivering electrical stimulation to the heart in a manner which provides a protective effect against subsequent ischemia is disclosed. The protective effect is produced by configuring a cardiac pacing device to intermittently switch from a normal operating mode to a stress augmentation mode in which the spatial pattern of depolarization is varied to thereby subject a particular region or regions of the ventricular myocardium to increased mechanical stress.

Claims

1. A cardiac rhythm management device, comprising:

a pacing channel for delivering pacing pulses to a selected ventricular myocardial site;

a controller for controlling the delivery of pacing pulses in accordance with a programmed pacing mode;

wherein the controller is programmed to switch from a normal operating mode to a stress augmentation mode in which a particular region or regions of the ventricular myocardium are subjected to increased mechanical stress as compared with the stress experienced by those regions during the normal operating mode; and

,

wherein the controller is programmed to switch to the stress augmentation mode upon expiration of a timer, where the timer is defined with an expiration which coincides with when the patient is expected to awaken from sleep, and to cease operating in the stress augmentation mode upon expiration of a specified time period.

2. The device of claim 1 wherein the normal operating mode is a primary pacing mode for delivering ventricular pacing therapy and wherein stress augmentation mode causes a different depolarization pattern than the primary pacing mode.

3. The device of claim 2 wherein the stress augmentation mode excites the ventricular myocardium at a site or sites different from the primary pacing mode.

4. The device of claim 2 wherein the switch from a primary pacing mode to a stress augmentation mode involves switching form bipolar pacing to unipolar pacing or vice-versa.

5. The device of claim 2 wherein the switch from a primary pacing mode to a stress augmentation mode involves switching which electrode of a bipolar pacing lead is the cathode and which electrode is the anode.

6. The device of claim 2 further comprising:

multiple pacing channels for delivering pacing pulses to a plurality of ventricular pacing sites; and

,

wherein the stress augmentation mode uses at least one pacing channel not used in the primary pacing mode.

7. A cardiac rhythm management device, comprising:

a pacing channel for delivering pacing pulses to a selected ventricular myocardial site;

a controller for controlling the delivery of pacing pulses in accordance with a programmed pacing mode;

a posture sensor interfaced to the controller;

wherein the controller is programmed to switch from a normal operating mode to a stress augmentation mode in which a particular region or regions of the ventricular myocardium are subjected to increased mechanical stress as compared with the stress experienced by those regions during the normal operating mode; and

,

wherein the controller is programmed to switch to the stress augmentation mode upon receiving a signal from the posture sensor indicating tat the patient'"'"'s posture has changed from a supine position to an erect or sitting position and to cease operating in the stress augmentation mode upon expiration of a specified time period.

8. The device of claim 7 wherein the normal operating mode is a primary pacing mode for delivering ventricular pacing therapy and wherein stress augmentation mode causes a different depolarization pattern than the primary pacing mode.

9. The device of claim 8 wherein the stress augmentation mode excites the ventricular myocardium at a site or sites different from the primary pacing mode.

10. The device of claim 8 wherein the switch from a primary pacing mode to a stress augmentation mode involves switching form bipolar pacing to unipolar pacing or vice-versa.

11. The device of claim 8 wherein the switch from a primary pacing mode to a stress augmentation mode involves switching which electrode of a bipolar pacing lead is the cathode and which electrode is the anode.

12. The device of claim 8 further comprising:

multiple pacing channels for delivering pacing pulses to a plurality of ventricular pacing sites; and

,

wherein the stress augmentation mode uses at least one pacing channel not used in the primary pacing mode.

13. The device of claim 7 wherein the controller is further programmed to switch to the stress augmentation mode for a specified time period upon receiving a signal from the posture sensor indicating that the patient'"'"'s posture has changed from a supine position to an erect or sitting position and if the time of day is within a defined wakeup window as determined by a time stamp.

14. A cardiac rhythm management device, comprising:

a pacing channel for delivering pacing pulses to a selected ventricular myocardial site;

a sensing channel for detecting intrinsic cardiac activity;

a controller for controlling the delivery of pacing pulses in accordance with a programmed pacing mode;

wherein the controller is programmed to determine an LF/HF ratio by analyzing data received from the sensing channel;

wherein the controller is programmed to switch from a normal operating mode to a stress augmentation mode in which a particular region or regions of the ventricular myocardium are subjected to increased mechanical stress as compared with the stress experienced by those regions during the normal operating mode; and

,

wherein the controller is programmed to switch to the stress augmentation mode when the LF/HF ratio is above a specified threshold value and to cease operating in the stress augmentation mode upon expiration of a specified time period.

15. The device of claim 14 wherein the normal operating mode is a primary pacing mode for delivering ventricular pacing therapy and wherein stress augmentation mode causes a different depolarization pattern than the primary pacing mode.

16. The device of claim 15 wherein the stress augmentation mode excites the ventricular myocardium at a site or sites different from the primary pacing mode.

17. The device of claim 15 wherein the switch from a primary pacing mode to a stress augmentation mode involves switching form bipolar pacing to unipolar pacing or vice-versa.

18. The device of claim 15 wherein the switch from a primary pacing mode to a stress augmentation mode involves switching which electrode of a bipolar pacing lead is the cathode and which electrode is the anode.

19. The device of claim 15 further comprising:

multiple pacing channels for delivering pacing pulses to a plurality of ventricular pacing sites; and

,

wherein the stress augmentation mode uses at least one pacing channel not used in the primary pacing mode.